STE Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 23:00):

Stats
Объем за сегодня	306 277
Средний объем	488 947
Рыночная капитализация	20.15B
EPS	$0 ( 2024-02-07 )
Дата следующего отчета о доходах	( $2.43 ) 2024-05-08
Last Dividend	$0.520 ( 2023-11-20 )
Next Dividend	$0 ( N/A )
P/E	35.83
ATR14	$0.119 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-22	Kohler Kenneth E	Sell	0	Ordinary Shares
2024-02-22	Kohler Kenneth E	Sell	2 136	Employee Stock Options (right to buy)
2024-02-22	Kohler Kenneth E	Sell	3 728	Employee Stock Options (right to buy)
2024-02-22	Kohler Kenneth E	Sell	2 764	Employee Stock Options (right to buy)
2024-02-22	Kohler Kenneth E	Sell	4 100	Employee Stock Options (right to buy)

INSIDER POWER
54.13
Last 98 transactions
Buy: 253 331 \| Sell: 67 940

Объем Корреляция

Длинно: 0.27 (neutral)

Кратко: -0.93 (very strong negative)

Signal:(40.213) Neutral

Steris plc Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Steris plc Корреляция - Валюта/Сырье

0.35
( neutral )

0.32
( neutral )

0.00
( neutral )

0.18
( neutral )

0.06
( neutral )

-0.63
( weak negative )

Steris plc Финансовые показатели

Annual	2023
Выручка:	$4.96B
Валовая прибыль:	$2.16B (43.56 %)
EPS:	$1.070

FY	2023
Выручка:	$4.96B
Валовая прибыль:	$2.16B (43.56 %)
EPS:	$1.070

FY	2022
Выручка:	$4.59B
Валовая прибыль:	$2.02B (43.98 %)
EPS:	$2.50

FY	2021
Выручка:	$3.11B
Валовая прибыль:	$1.34B (43.22 %)
EPS:	$4.66

Financial Reports:

No articles found.

Steris plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.470 (N/A)	$0.470 (N/A)	$0.470 (N/A)	$0.470 (N/A)	$0.520 (N/A)	$0.520 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Steris plc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.44 - Stable (11.29%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0400	2005-05-26
Last Dividend	$0.520	2023-11-20
Next Dividend	$0	N/A
Payout Date	2023-12-21
Next Payout Date	N/A
# dividends	75	--
Total Paid Out	$19.66	--
Avg. Dividend % Per Year	0.62%	--
Score	4.85	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.44
Div. Directional Score	7.86	--

Next Divdend (Est)
(2024-07-01)

$0.529 Estimate 39.86 %

Dividend Stability

0.80 Good

Dividend Score

4.85

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2005	$0.120	0.52%
2006	$0.170	0.67%
2007	$0.220	0.86%
2008	$0.280	0.97%
2009	$2.41	10.10%
2010	$0.520	1.84%
2011	$0.640	1.73%
2012	$0.720	2.39%
2013	$0.800	2.28%
2014	$0.880	1.86%
2015	$0.960	1.47%
2016	$1.060	1.43%
2017	$1.180	1.73%
2018	$1.300	1.47%
2019	$1.420	1.36%
2020	$1.540	1.02%
2021	$1.660	0.88%
2022	$1.800	0.74%
2023	$1.980	1.07%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.105	1.500	7.90	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0496	1.200	8.35	10.00	[0 - 0.3]
returnOnEquityTTM	0.0912	1.500	-0.0981	-0.147	[0.1 - 1]
payoutRatioTTM	0.345	-1.000	6.55	-6.55	[0 - 1]
currentRatioTTM	2.43	0.800	2.86	2.29	[1 - 3]
quickRatioTTM	1.269	0.800	7.24	5.79	[0.8 - 2.5]
cashRatioTTM	0.214	1.500	9.92	10.00	[0.2 - 2]
debtRatioTTM	0.307	-1.500	4.89	-7.33	[0 - 0.6]
interestCoverageTTM	5.90	1.000	8.92	8.92	[3 - 30]
operatingCashFlowPerShareTTM	9.46	2.00	6.85	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.01	2.00	6.99	10.00	[0 - 20]
debtEquityRatioTTM	0.547	-1.500	7.81	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.436	1.000	6.07	6.07	[0.2 - 0.8]
operatingProfitMarginTTM	0.151	1.000	8.98	8.98	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.266	1.000	9.63	9.63	[0.2 - 2]
assetTurnoverTTM	0.473	0.800	-0.181	-0.145	[0.5 - 2]
Total Score				11.28

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	35.54	1.000	6.51	0	[1 - 100]
returnOnEquityTTM	0.0912	2.50	-0.0631	-0.147	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.01	2.00	8.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.996	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	9.46	2.00	6.85	10.00	[0 - 30]
payoutRatioTTM	0.345	1.500	6.55	-6.55	[0 - 1]
pegRatioTTM	-0.621	1.500	-7.48	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.173	1.000	8.18	0	[0.1 - 0.5]
Total Score				4.44

Steris plc

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.